$BIEL .. "The FDA will now review the comments. We continue to focus on our efforts on completing our clinical trials and assembling the data we will file as soon as the FDA announces the new rules."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.